What is imagined
The company’s operating model, portfolio, candidate identifiers, development stages, and team disciplines are fictional. No real trials, results, approvals, facilities, employees, partnerships, fundraising, or licensing activities are asserted. The website does not offer treatment, medical advice, securities, or actual employment.
What is grounded in real context
Kernicterus is lasting neurological injury related to bilirubin toxicity. Prevention and the needs of people with established injury are distinct. The scientific background below informs the problem statement; it does not validate the fictional Kitheras portfolio.
Design and artwork
Kitheras has its own visual identity, original copy, and scientific storytelling. The neural imagery was generated as conceptual artwork, not as an anatomical diagram, research result, or depiction of company facilities.
Scientific and community background
- Review of bilirubin neurotoxicity I: molecular biology and neuropathology of disease (2019) ↗
- Review of bilirubin neurotoxicity II: preventing and treating acute bilirubin encephalopathy and kernicterus spectrum disorders (2019) ↗
- Chronic bilirubin encephalopathy: diagnosis and outcome (2010) ↗
- CDC: Jaundice and Kernicterus facts (archived) ↗
- PIC-K: Kernicterus and the family mission ↗
- cureKI: the founding-stage research mission ↗
Links are contextual resources; they do not imply endorsement or affiliation. Clinical context requires qualified review before any real company launch.